Trial
NCT05378113
Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
—
Condition
Injection Site Irritation
Intervention
Ondansetron
Why stopped
Study was terminated due to enrollment challenges following the relocation of orthopedic procedures to a different hospital.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-24